S E Mirski
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cancer therapeutics and mechanisms 19
- Glycosylation and Glycoproteins Research 3
- Oncology 16
- Lung Cancer Research Studies 12
- Drug Transport and Resistance Mechanisms 4
- CAR-T cell therapy research 2
- Co-authors
- Susan P.C. Cole (24 shared papers)James H. Gerlach (7 shared papers)Qiang Yu (3 shared papers)H. Downes (1 shared paper)Daniel M. Sullivan (1 shared paper)Ralph Zirngibl (2 shared papers)Peter A. Greer (2 shared papers)Pamela W. Feldhoff (1 shared paper)
- Journals
- Lung Cancer (5 papers)Experimental Cell Research (4 papers)Annals of the New York Academy of Sciences (2 papers)International Journal of Cancer (2 papers)Gene (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
S E Mirski
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Oncology 762
- Toxicology 68
- Molecular Biology 934
- Biochemistry 50
- Infectious Diseases 99
Countries citing papers authored by S E Mirski
This map shows the geographic impact of S E Mirski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Mirski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Mirski more than expected).
Fields of papers citing papers by S E Mirski
This network shows the impact of papers produced by S E Mirski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Mirski. The network helps show where S E Mirski may publish in the future.
Co-authors
The 25 scholars most cited alongside S E Mirski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. | 1987 | 299 |
| 2 | 1992 | 146 | |
| 3 | 1990 | 78 | |
| 4 | 1994 | 62 | |
| 5 | Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. | 1995 | 61 |
| 6 | Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. | 1997 | 60 |
| 7 | 1998 | 59 | |
| 8 | 1994 | 54 | |
| 9 | 1997 | 54 | |
| 10 | 1999 | 42 | |
| 11 | Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA. | 1983 | 37 |
| 12 | 1983 | 36 | |
| 13 | 2001 | 35 | |
| 14 | 1994 | 32 | |
| 15 | 1997 | 32 | |
| 16 | 1986 | 29 | |
| 17 | 2002 | 25 | |
| 18 | 2007 | 24 | |
| 19 | 2003 | 23 | |
| 20 | 1994 | 23 |
About S E Mirski
S E Mirski is a scholar working on Molecular Biology, Oncology, Neurology, Toxicology and Immunology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (19 papers), Lung Cancer Research Studies (12 papers), Drug Transport and Resistance Mechanisms (4 papers), Glycosylation and Glycoproteins Research (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Neuroblastoma Research and Treatments (3 papers), CAR-T cell therapy research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Oncology (762 citations), Toxicology (68 citations), Molecular Biology (934 citations), Biochemistry (50 citations) and Infectious Diseases (99 citations). S E Mirski has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Susan P.C. Cole, James H. Gerlach, Qiang Yu, H. Downes, Daniel M. Sullivan, Ralph Zirngibl, Peter A. Greer, Pamela W. Feldhoff, John Bienenstock and A. Dean Befus. Their work appears in journals such as Lung Cancer, Experimental Cell Research, Annals of the New York Academy of Sciences, International Journal of Cancer and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.